Untech inc

Untech is a biotechnology and pharmaceutical company dedicated to developing innovative treatments for chronic wounds. The company has developed a proprietary gel designed to address the three primary therapeutic requirements for wound healing: acting as an anti-pathogenic agent that disrupts biofilm, providing anesthetic relief, and promoting tissue regeneration through the inhibition of harmful enzymes and free radicals. This technology aims to facilitate home-based treatment for patients suffering from conditions such as diabetic foot, pressure ulcers, and venous ulcers. By targeting biofilm-forming bacteria, which are often resistant to conventional antibiotics and antiseptics, Untech seeks to overcome the challenges that have historically made chronic wound healing difficult to achieve. The company's efforts are supported by a team of scientists and entrepreneurs with extensive experience in the pharmaceutical and biotechnology sectors, who have received international recognition from various academic and innovation institutions for their research and development. Their mission focuses on improving the quality of life for millions of individuals globally by transforming wound management protocols.